Failure of neural responses to safety cues in schizophrenia

Archives of General Psychiatry

Volumn 69, Issue 9, 2012, Pages 893-903

  Holt, Daphne J ^a,b,c   Coombs III, Garth ^a,b   Zeidan, Mohamed A ^a,b   Goff, Donald C ^a,c   Milad, Mohammed R ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BOLD SIGNAL; BRAIN DYSFUNCTION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEAR; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MEMORY CONSOLIDATION; NEGATIVE SYNDROME; NERVE POTENTIAL; NEUROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SCANNER; PHENOTYPE; POSTERIOR CINGULATE; RECALL; SAFETY; SCHIZOPHRENIA; SKIN CONDUCTANCE; VENTROMEDIAL PREFRONTAL CORTEX;

AMYGDALA; AROUSAL; AUTONOMIC NERVOUS SYSTEM; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; CONDITIONING, CLASSICAL; CROSS-SECTIONAL STUDIES; CUES; DOMINANCE, CEREBRAL; EXTINCTION, PSYCHOLOGICAL; FEAR; GALVANIC SKIN RESPONSE; GYRUS CINGULI; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MENTAL RECALL; OXYGEN; PREFRONTAL CORTEX; RETENTION (PSYCHOLOGY); SAFETY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84866053292     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.2310     Document Type: Article

References (100)

1. Polgár P, Farkas M, Nagy O, Kelemen O, Réthelyi J, Bitter I, Myers CE, Gluck MA, Kéri S. How to find the way out from four rooms? the learning of "chaining" associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res. 2008;99(1-3):200-207.
2. Strauss GP, Frank MJ, Waltz JA, Kasanova Z, Herbener ES, Gold JM. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biol Psychiatry. 2011;69(5):424-431.
3. Waltz JA, Frank MJ, Wiecki TV, Gold JM. Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling. Neuropsychology. 2011;25(1):86-97.
4. Barch DM, Dowd EC. Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophr Bull. 2010; 36(5):919-934.
5. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M. The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci. 2005; 255(3):167-173.
6. Krabbendam L, Janssen I, Bak M, Bijl RV, de Graaf R, van Os J. Neuroticism and low self-esteem as risk factors for psychosis. Soc Psychiatry Psychiatr Epidemiol. 2002;37(1):1-6.
7. Krabbendam L, van Os J. Affective processes in the onset and persistence of psychosis. Eur Arch Psychiatry Clin Neurosci. 2005;255(3):185-189.
8. Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J. Depression in first-episode schizophrenia. Am J Psychiatry. 1993;150(11):1643- 1648.
9. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Könnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases: a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77(1):11-24.
10. Freeman D, Garety PA. Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behav Res Ther. 2003;41(8):923-947.
11. Norman RM, Malla AK. Correlations over time between dysphoric mood and symptomatology in schizophrenia. Compr Psychiatry. 1994;35(1):34-38.
12. Holt DJ, Titone D, Long LS, Goff DC, Cather C, Rauch SL, Judge A, Kuperberg GR. The misattribution of salience in delusional patients with schizophrenia. Schizophr Res. 2006;83(2-3):247-256.
13. Phillips ML, David AS. Abnormal visual scan paths: a psychophysiological marker of delusions in schizophrenia. Schizophr Res. 1998;29(3):235-245.
14. Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA. Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull. 2008;34(5):835-847.
15. Weiler JA, Bellebaum C, Brüne M, Juckel G, Daum I. Impairment of probabilistic reward-based learning in schizophrenia. Neuropsychology. 2009;23(5):571-580.
16. Romaniuk L, Honey GD, King JR, Whalley HC, McIntosh AM, Levita L, Hughes M, Johnstone EC, Day M, Lawrie SM, Hall J. Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia. Arch Gen Psychiatry. 2010;67(12):1246-1254.
17. Holt DJ, Lebron-Milad K, Milad MR, Rauch SL, Pitman RK, Orr SP, Cassidy BS, Walsh JP, Goff DC. Extinction memory is impaired in schizophrenia. Biol Psychiatry. 2009;65(6):455-463.
18. Jensen J, Willeit M, Zipursky RB, Savina I, Smith AJ, Menon M, Crawley AP, Kapur S. The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology. 2008;33(3):473-479.
19. Spain B. Eyelid conditioning and arousal in schizophrenic and normal subjects. J Abnorm Psychol. 1966;71(4):260-266.
20. Sears LL, Andreasen NC, O'Leary DS. Cerebellar functional abnormalities in schizophrenia are suggested by classical eyeblink conditioning. Biol Psychiatry. 2000;48(3):204-209.
21. Hofer E, Doby D, Anderer P, Dantendorfer K. Impaired conditional discrimination learning in schizophrenia. Schizophr Res. 2001;51(2-3):127-136.
22. Kosmidis MH, Breier A, Fantie BD. Avoidance learning in schizophrenia: a dissociation between the effects of aversive and non-aversive stimuli. Schizophr Res. 1999;38(1):51-59.
23. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155-184.
24. Quirk GJ. Memory for extinction of conditioned fear is long-lasting and persists following spontaneous recovery. Learn Mem. 2002;9(6):402-407.
25. Bouton ME, Moody EW. Memory processes in classical conditioning. Neurosci Biobehav Rev. 2004;28(7):663-674.
26. Milad MR, Rauch SL, Pitman RK, Quirk GJ. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol. 2006;73(1):61-71.
27. Bouton ME, Westbrook RF, Corcoran KA, Maren S. Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry. 2006;60(4):352-360.
28. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol. 2003; 23(4-5):727-738.
29. Likhtik E, Popa D, Apergis-Schoute J, Fidacaro GA, Paré D. Amygdala intercalated neurons are required for expression of fear extinction. Nature. 2008; 454(7204):642-645.
30. Herry C, Ciocchi S, Senn V, Demmou L, Müller C, Lüthi A. Switching on and off fear by distinct neuronal circuits. Nature. 2008;454(7204):600-606.
31. Amano T, Unal CT, Paré D. Synaptic correlates of fear extinction in the amygdala. Nat Neurosci. 2010;13(4):489-494.
32. Quirk GJ, Garcia R, González-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry. 2006;60(4):337-343.
33. Quirk GJ, Russo GK, Barron JL, Lebron K. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci. 2000;20(16):6225-6231.
34. Lebrón K, Milad MR, Quirk GJ. Delayed recall of fear extinction in rats with lesions of ventral medial prefrontal cortex. Learn Mem. 2004;11(5):544-548.
35. Morgan MA, Schulkin J, LeDoux JE. Ventral medial prefrontal cortex and emotional perseveration: thememory for prior extinction training. Behav Brain Res. 2003;146(1-2):121-130.
36. Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron. 2007;53(6):871-880.
37. Milad MR, Quirk GJ. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature. 2002;420(6911):70-74.
38. Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci. 2006;26(37):9503-9511.
39. Phelps EA, Delgado MR, Nearing KI, LeDoux JE. Extinction learning in humans: role of the amygdala and vmPFC. Neuron. 2004;43(6):897-905.
40. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry. 2007;62(5):446-454.
41. Milad MR, Quinn BT, Pitman RK, Orr SP, Fischl B, Rauch SL. Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proc Natl Acad Sci U S A. 2005;102(30):10706-10711.
42. Hartley CA, Fischl B, Phelps EA. Brain structure correlates of individual differences in the acquisition and inhibition of conditioned fear. Cereb Cortex. 2011;21(9):1954-1962.
43. Milad MR, Orr SP, Pitman RK, Rauch SL. Context modulation of memory for fear extinction in humans. Psychophysiology. 2005;42(4):456-464.
44. Holt DJ, Lakshmanan B, Freudenreich O, Goff DC, Rauch SL, Kuperberg GR. Dysfunction of a cortical midline network during emotional appraisals in schizophrenia. Schizophr Bull. 2011;37(1):164-176.
45. Reske M, Habel U, Kellermann T, Backes V, Jon Shah N, von Wilmsdorff M, Gaebel W, Zilles K, Schneider F. Differential brain activation during facial emotion discrimination in first-episode schizophrenia. J Psychiatr Res. 2009;43(6):592-599.
46. Taylor SF, Welsh RC, Chen AC, Velander AJ, Liberzon I. Medial frontal hyperactivity in reality distortion. Biol Psychiatry. 2007;61(10):1171-1178.
47. Williams LM, Das P, Harris AW, Liddell BB, Brammer MJ, Olivieri G, Skerrett D, Phillips ML, David AS, Peduto A, Gordon E. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry. 2004;161(3):480-489.
48. Williams LM, Das P, Liddell BJ, Olivieri G, Peduto AS, David AS, Gordon E, Harris AW. Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res. 2007;155(1):29-44.
49. Holt DJ, Cassidy BS, Andrews-Hanna JR, Lee SM, Coombs G, Goff DC, Gabrieli JD, Moran JM. An anterior-to-posterior shift in midline cortical activity in schizophrenia during self-reflection. Biol Psychiatry. 2011;69(5):415-423.
50. Vinogradov S, Luks TL, Schulman BJ, Simpson GV. Deficit in a neural correlate of reality monitoring in schizophrenia patients. Cereb Cortex. 2008;18 (11):2532-2539.
51. Brüne M, Lissek S, Fuchs N, Witthaus H, Peters S, Nicolas V, Juckel G, Tegenthoff M. An fMRI study of theory of mind in schizophrenic patients with "passivity" symptoms. Neuropsychologia. 2008;46(7):1992-2001.
52. Walter H, Ciaramidaro A, Adenzato M, Vasic N, Ardito RB, Erk S, Bara BG. Dysfunction of the social brain in schizophrenia is modulated by intention type: an fMRI study. Soc Cogn Affect Neurosci. 2009;4(2):166-176.
53. Milad MR, Goldstein JM, Orr SP, Wedig MM, Klibanski A, Pitman RK, Rauch SL. Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci. 2006;120(6):1196-1203.
54. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. New York, New York: The New York State Psychiatric Institute, Biometrics Research; 1995.
55. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
56. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto, California: Consulting Psychologists' Press; 1983.
57. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
58. Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, Zeidan MA, Handwerger K, Orr SP, Rauch SL. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry. 2009;66(12):1075-1082.
59. Milad MR, Quirk GJ, Pitman RK, Orr SP, Fischl B, Rauch SL. A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry. 2007;62(10):1191-1194.
60. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York, New York: Thieme Medical Publishers, Inc; 1988.
61. Pezze MA, Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol. 2004;74(5):301-320.
62. Mueller D, Bravo-Rivera C, Quirk GJ. Infralimbic D2 receptors are necessary for fear extinction and extinction-related tone responses. Biol Psychiatry. 2010;68(11):1055-1060.
63. Phillips ML, Williams L, Senior C, Bullmore ET, Brammer MJ, Andrew C, Williams SC, David AS. A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry Res. 1999;92(1):11-31.
64. Howe ES. GSR conditioning in anxiety states, normals, and chronic functional schizophrenic subjects. J Abnorm Psychol. 1958;56(2):183-189.
65. Surguladze S, Russell T, Kucharska-Pietura K, Travis MJ, Giampietro V, David AS, Phillips ML. A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biol Psychiatry. 2006;60(5):423-431.
66. Seiferth NY, Pauly K, Habel U, Kellermann T, Shah NJ, Ruhrmann S, Klosterkötter J, Schneider F, Kircher T. Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage. 2008;40(1):289-297.
67. Anticevic A, Van Snellenberg JX, Cohen RE, Repovs G, Dowd EC, Barch DM. Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies. Schizophr Bull. 2012;38 (3):608-621.
68. Holt DJ, Kunkel L, Weiss AP, Goff DC, Wright CI, Shin LM, Rauch SL, Hootnick J, Heckers S. Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. Schizophr Res. 2006;82(2-3):153-162.
69. Vogt BA, Laureys S. Posterior cingulate, precuneal and retrosplenial cortices: cytology and components of the neural network correlates of consciousness. Prog Brain Res. 2005;150:205-217.
70. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network:anatomy, function, and relevance to disease Ann N Y Acad Sci. 2008;1124:1-38.
71. Bluhm RL, Miller J, Lanius RA, Osuch EA, Boksman K, Neufeld RW, Théberge J, Schaefer B, Williamson P. Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network. Schizophr Bull. 2007;33(4):1004-1012.
72. Wagner AD, Shannon BJ, Kahn I, Buckner RL. Parietal lobe contributions to episodic memory retrieval. Trends Cogn Sci. 2005;9(9):445-453.
73. Kobayashi Y, Amaral DG. Macaque monkey retrosplenial cortex, II: cortical afferents. J Comp Neurol. 2003;466(1):48-79.
74. Manoach DS, Cain MS, Vangel MG, Khurana A, Goff DC, Stickgold R. A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia. Biol Psychiatry. 2004;56(12):951-956.
75. Leeson VC, Robbins TW, Franklin C, Harrison M, Harrison I, Ron MA, Barnes TR, Joyce EM. Dissociation of long-term verbal memory and fronto-executive impairment in first-episode psychosis. Psychol Med. 2009;39(11):1799-1808.
76. Herbener ES. Impairment in long-term retention of preference conditioning in schizophrenia. Biol Psychiatry. 2009;65(12):1086-1090.
77. Kringelbach ML. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci. 2005;6(9):691-702.
78. Grabenhorst F, Rolls ET. Value, pleasure and choice in the ventral prefrontal cortex. Trends Cogn Sci. 2011;15(2):56-67.
79. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28(3):309-369.
80. Li M, Parkes J, Fletcher PJ, Kapur S. Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases. Pharmacol Biochem Behav. 2004;78(4):811-819.
81. Blackburn JR, Pfaus JG, Phillips AG. Dopamine functions in appetitive and defensive behaviours. Prog Neurobiol. 1992;39(3):247-279.
82. Ponnusamy R, Nissim HA, Barad M. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Learn Mem. 2005; 12(4):399-406.
83. Hikind N, Maroun M. Microinfusion of the D1 receptor antagonist, SCH23390 into the IL but not the BLA impairs consolidation of extinction of auditory fear conditioning. Neurobiol Learn Mem. 2008;90(1):217-222.
84. Menon M, Jensen J, Vitcu I, Graff-Guerrero A, Crawley A, Smith MA, Kapur S. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biol Psychiatry. 2007;62(7):765-772.
85. Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wüstenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl). 2006;187(2):222-228.
86. Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl). 2008;196(4):673-684.
87. Kirsch P, Ronshausen S, Mier D, Gallhofer B. The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients. Pharmacopsychiatry. 2007;40(5):196-198.
88. Fontanez-Nuin DE, Santini E, Quirk GJ, Porter JT. Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons. Cereb Cortex. 2011;21(3):727-735.
89. McCallum J, Kim JH, Richardson R. Impaired extinction retention in adolescent rats: effects of D-cycloserine. Neuropsychopharmacology. 2010;35(10):2134-2142.
90. Langton JM, Richardson R. The effect of D-cycloserine on immediate vs delayed extinction of learned fear. Learn Mem. 2010;17(11):547-551.
91. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry. 2008;63(12):1118-1126.
92. Peters J, Dieppa-Perea LM, Melendez LM, Quirk GJ. Induction of fear extinction with hippocampal-infralimbic BDNF. Science. 2010;328(5983):1288-1290.
93. Choi DC, Maguschak KA, Ye K, Jang SW, Myers KM, Ressler KJ. Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci U S A. 2010;107(6):2675-2680.
94. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl). 2003;169(3-4):215-233.
95. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry. 2001;158(9):1367-1377.
96. Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry. 2011;24(2):122-127.
97. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry. 2011;16(9):960-972.
98. Ho BC, Andreasen NC, Dawson JD, Wassink TH. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry. 2007;164(12):1890-1899.
99. Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF. Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophr Res. 2008;106(2-3):320-327.
100. Gottlieb JD, Cather C, Shanahan M, Creedon T, Macklin EA, Goff DC. D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia. Schizophr Res. 2011;131(1-3):69-74.